The ER test is typically performed on a sample of cancer tissue obtained during a biopsy or surgery. The tissue is treated with special antibodies that bind to the estrogen receptors. The presence and amount of receptor binding is then measured using a technique called immunohistochemistry (IHC). The results are reported as a percentage of cancer cells that test positive for estrogen receptors.
